Trial Profile
A Multi-Center Observational Clinical Study of Screening of Non-Small-Cell Lung Cancer With Bone Metastasis and Efficacy and Safety of Those Receiving Bisphosphonates.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Dec 2013
Price :
$35
*
At a glance
- Drugs Zoledronic acid (Primary) ; Calcium; Vitamin D
- Indications Cancer metastases; Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms BLEST
- 09 Dec 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 03 Feb 2012 Planned end date changed from 1 Oct 2011 to 1 May 2012 as reported by ClinicalTrials.gov.
- 03 Feb 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.